Zefit develops biomarkers and drugs for neurological disorders, utilizing zebrafish and innovative diagnostic tools for new drug discovery.

Vision and Mission: Zefit aims to advance the treatment of CNS diseases through their unique zebrafish platform, improving therapeutic outcomes and patient care.

Noteworthy Points:

• Established in 2018 with a focus on CNS disease drug development.
• Developed an EEG measurement system using automation and parallelization technology.
• Recognized for its CNS disease target material screening platform.